Director, Wolfson Molecular Imaging Centre (2019-2020)

Senior Lecturer in Psychiatry (2005-2020)

Honorary General Secretary (2017-2022), British Association for Psychopharmacology

President, Manchester Medical Society Psychiatry Section (2018-2019)

Fellow of the Royal College of Psychiatrists

Editorial Advisory Board, Journal of Psychopharmacology (2010-2022)

Peter Talbot qualified in Medicine from the University of Bristol, and completed his specialist clinical training and MD in Psychiatry in his native Northern Ireland. His postdoctoral research training was in Positron Emission Tomography (PET) neuroimaging under the supervision of Marc Laruelle at Columbia University in New York, followed by appointment as Assistant Professor in Psychiatry there in 2004. He joined the University of Manchester in 2005 as Senior Lecturer in Molecular Neuroimaging and was appointed Director of the Wolfson Molecular Imaging Centre in 2019. His research interest is the use of PET to investigate abnormal brain mechanisms in severe mental illness, particularly psychosis, affective disorders and impulsivity. He is active in neuroscience and psychopharmacology teaching both locally (Lead for undergraduate and postgraduate modules; Past President of the Manchester Medical Society Psychiatry Section) and nationally for the BAP (Course Organiser for the Schizophrenia Module; lecturer on the Affective Disorders Module and Depression Masterclass).

In his clinical work he is Honorary Consultant Psychiatrist with Greater Manchester Mental Health NHS Foundation Trust and was Director of the Specialist Service for Affective Disorders, a regional tertiary-level NHS clinic, until July 2019.

Peter's principal scientific research interest is the use of PET molecular brain imaging in drug development and to investigate biological abnormalities in mental disorders such as schizophrenia, depression, bipolar disorder and severe impulsivity.

Teacher on national British Association for Psychopharmacology (BAP) biannual Masterclass in Psychopharmacology training courses, London.

Course Organiser 2013-2017, BAP Certificate in Psychopharmacology Schizophrenia module.

Lecturer, MSc in Neuroimaging in Cognitive and Clinical Neuroscience, University of Manchester School of Psychological Sciences

Lecturer, MRCPsych course, North West School of Psychiatry.

Academic Advisor for University of Manchester Medical School.

Undergraduate Personal Excellence Path (PEP) Supervisor and Examiner.

Division of Medical Education MB ChB Curriculum: Phase I Module Co-Lead (Mind & Movement) 2011-present.

Division of Medical Education MB ChB Curriculum: Phase 2 Mental Health Block Lead 2016-17.

Royal College of Psychiatrists

Council Member (elected), British Association for Psychopharmacology 2015-2017

Honorary General Secretary (elected), British Association for Psychopharmacology 2017-2022

Vice Chair, Medicines Management Sub-Committee, Greater Manchester Mental Health NHS Foundation Trust

Design, regulatory applications, conduct, analysis and interpretation of positron emission tomography (PET) studies in patients with mental disorders and healthy subjects. Particular expertise in radiotracers for serotonin and dopamine systems. Clinical trial methodology and conduct in resistant depression.

MB ChB, MD, MRCPsych, FRCPsych

Diploma in Mental Health, with Distinction, Queen’s University Belfast, N. Ireland

Vocational Training in General Practice

Diploma in Anaesthetics, Royal College of Anaesthetists, UK.